Human Papillomavirus 45 Genetic Variation and Cervical Cancer Risk Worldwide
Carregando...
Citações na Scopus
29
Tipo de produção
article
Data de publicação
2014
Editora
AMER SOC MICROBIOLOGY
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
CHEN, Alyce A.
HEIDEMAN, Danielle A. M.
BOON, Debby
GHEIT, Tarik
SNIJDERS, Peter J. F.
TOMMASINO, Massimo
FRANCESCHI, Silvia
CLIFFORD, Gary M.
Autor de Grupo de pesquisa
IARC HPV Variant Study Grp
Editores
Coordenadores
Organizadores
Citação
JOURNAL OF VIROLOGY, v.88, n.8, p.4514-4521, 2014
Resumo
Human papillomavirus 45 (HPV45) is a member of the HPV18-related alpha-7 species and accounts for approximately 5% of all cervical cancer cases worldwide. This study evaluated the genetic diversity of HPV45 and the association of HPV45 variants with the risk of cervical cancer by sequencing the entire E6 and E7 open reading frames of 300 HPV45-positive cervical samples from 36 countries. A total of 43 HPV45 sequence variants were identified that formed 5 phylogenetic sublineages, A1, A2, A3, B1, and B2, the distribution of which varied by geographical region. Among 192 cases of cervical cancer and 101 controls, the B2 sublineage was significantly overrepresented in cervical cancer, both overall and in Africa and Europe separately. We show that the sequence analysis of E6 and E7 allows the classification of HPV45 variants and that the risk of cervical cancer may differ by HPV45 variant sublineage.
Palavras-chave
Referências
- Alibegashvili T, 2011, CANCER EPIDEMIOL, V35, P465, DOI 10.1016/j.canep.2010.12.006
- Aruhuri B, 2012, CANCER PREV RES, V5, P746, DOI 10.1158/1940-6207.CAPR-11-0515
- Bardin A, 2008, EUR J CANCER, V44, P557, DOI 10.1016/j.ejca.2007.12.001
- Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008
- Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002
- Berumen J, 2001, J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325
- BOSCH FX, 1995, J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796
- Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8
- Chen AA, 2014, VIROLOGY, V448, P356, DOI 10.1016/j.virol.2013.10.033
- Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183
- Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072565
- Chen Z, 2009, J VIROL, V83, P1443, DOI 10.1128/JVI.02068-08
- Clifford G, 2008, INT J CANCER, V122, P1684, DOI 10.1002/ijc.23282
- Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9
- Cornet I, 2013, BRIT J CANCER, V108, P240, DOI 10.1038/bjc.2012.508
- Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12
- de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033
- De Vuyst H, 2012, INT J CANCER, V131, P949, DOI 10.1002/ijc.26470
- Dondog B, 2008, CANCER EPIDEM BIOMAR, V17, P1731, DOI 10.1158/1055-9965.EPI-07-2796
- FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941
- Franceschi S, 2003, INT J CANCER, V107, P127, DOI 10.1002/ijc.11350
- Gheit T, 2011, CANCER EPIDEM BIOMAR, V20, P1315, DOI 10.1158/1055-9965.EPI-10-1187
- Godinez JM, 2013, INFECT GENET EVOL, V13, P96, DOI 10.1016/j.meegid.2012.09.011
- Guan P, 2013, INT J CANCER, V132, P248, DOI 10.1002/ijc.27663
- Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485
- Hammouda D, 2005, INT J CANCER, V113, P483, DOI 10.1002/ijc.20600
- Hesselink AT, 2009, INT J CANCER, V124, P381, DOI 10.1002/ijc.23940
- Keita N, 2009, BRIT J CANCER, V101, P202, DOI 10.1038/sj.bjc.6605140
- Khodakarami N, 2012, INT J CANCER, V131, pE156, DOI 10.1002/ijc.26488
- Li LK, 2006, BRIT J CANCER, V95, P1593, DOI 10.1038/sj.bjc.6603450
- Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396
- Liu Y, 1999, J VIROL, V73, P7297
- Mbaye EHS, 2014, J MED VIROL, V86, P248, DOI 10.1002/jmv.23719
- Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641
- NAGHASHFAR ZS, 1987, J GEN VIROL, V68, P3073, DOI 10.1099/0022-1317-68-12-3073
- Ntova CK, 2012, INT J MOL SCI, V13, P1, DOI 10.3390/ijms13010001
- Sathish N, 2005, CANCER LETT, V229, P93, DOI 10.1016/j.canlet.2005.04.026
- Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179
- Sherpa ATL, 2010, CANCER CAUSE CONTROL, V21, P323, DOI 10.1007/s10552-009-9467-z
- Sotlar K, 2004, J MED VIROL, V74, P107, DOI 10.1002/jmv.20153
- van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002
- Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959
- Wu RF, 2007, INT J CANCER, V121, P1306, DOI 10.1002/ijc.22726
- Zuna RE, 2009, INT J CANCER, V125, P2609, DOI 10.1002/ijc.24706